Medical AI Alliance
← Company Index
Medical AIKOSDAQ 382150

Oncocross Co.,Ltd.

Official website

Founded in 2015, Oncocross provides the disease-drug matching AI platform RAPTOR AI and the oncology-specialized ONCO-RAPTOR AI.

As of 2026-10-10, Oncocross Co.,Ltd. has 15 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2015 and listed on KOSDAQ in 2024, Oncocross is an AI drug discovery platform company. It offers the transcriptome/proteome-based disease-drug matching platform RAPTOR AI (v2.0), the proteomics analysis service Neo Omics, the oncology-specialized ONCO-RAPTOR AI, and ONCOfind AI, an early cancer diagnosis aid still under development. RAPTOR AI draws on a database of about 500 disease cohorts and roughly 25,000 compounds to provide indication-selection and indication-expansion analysis services that generate revenue, supported by two in-house research institutes -- the Bio Research Institute (established August 2015) and the AI Research Institute (established December 2019).

Products & technology

  • RAPTOR AITranscriptome/proteome-based disease-drug matching and optimal indication/combination drug screening (v2.0 extends to ADC and TPD modalities)
  • ONCO-RAPTOR AITranscriptome-based prediction of cancer-type specificity and companion diagnostic markers for anticancer drugs
  • ONCOfind AIAid for early cancer diagnosis and site-of-origin detection
  • Neo OmicsB2B proteomics analysis service supporting drug mechanism understanding and biomarker discovery

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

RAPTOR AI v2.0 고도화 · Expansion to multi-omics (genome-transcriptome-proteome) analysis, including new modalities such as ADC and TPD

Digital Bio Banking · Pursuing MOUs with major domestic hospitals and building digitized clinical data and cohorts

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched
Show 5 more publications

Patents

KIPRIS · applicant-matched
Show 98 more patents

AI reads

MAA server logs · IP-verified
53
Times AI engines pulled Oncocross Co.,Ltd.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

2
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

51
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

12
live 0
Last 7 days
41
live 1
Last 30 days
53
live 2
All time
  • OpenAIChatGPT-Userlive2
  • OpenAIOAI-SearchBot37
  • PerplexityPerplexityBot7
  • GoogleGoogleOther4
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Oncocross Co.,Ltd. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · regulatory approvals. Send us materials and we will add them

Companies in the same categoryMedical AI

SEERS Co., Ltd.100

Founded in 2009, SEERS provides the wearable ECG analysis solution mobiCARE and the inpatient monitoring solution thynC, based on AI vital-sign analytics.

INFINITT Healthcare Co., Ltd.85

Founded in 2002, INFINITT Healthcare provides PACS-centered medical imaging software and AI diagnostic aids across multiple clinical specialties.

SyntekaBio,Inc.85

Founded in 2009, SyntekaBio provides genomic big data-based AI drug discovery platforms DeepMatcher and NEO-ARS, along with the NGS-ARS precision medicine service.

DEEPNOID Inc.85

Founded in 2008 and listed on KOSDAQ in 2021, DEEPNOID develops medical and industrial AI imaging solutions like DEEP:NEURO.

VUNO, Inc.85

Founded in 2014, VUNO provides AI-based vital-sign and medical imaging diagnostic solutions, including VUNO Med-DeepCARS and VUNO Med-Fundus AI.

JLK, Inc.80

JLK offers the stroke AI solution MEDIHUB STROKE and holds 78 global regulatory approvals, including US FDA and Japan PMDA clearances.

Lunit Inc.80

Founded in 2013, Lunit provides AI-driven cancer screening and oncology solutions through Lunit INSIGHT and Lunit SCOPE.

Acryl Inc.75

Founded in 2011, Acryl provides the integrated AI platform Jonathan and the healthcare-specialized AI platform Nadia.

LEMON HEALTHCARE Co.70

Founded in 2017 and listed on KOSDAQ in 2026, Lemon Healthcare operates the LDB medical mydata relay platform for hospitals and insurers.

SELVAS AI Inc.60

SELVAS AI provides voice and language AI technologies through its HCI and AI Digital Transformation business units.

ezCaretech Co., LTD60

Founded in 2001, ezCaretech provides the hospital information systems BESTCare (on-premise) and EDGE&NEXT (cloud-based).

BITComputer55

Founded in 1985, BITComputer provides hospital information systems such as bitnixHIS and CLEMR, alongside digital healthcare and IT education businesses.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition